13 studies found for:    "Stevens-Johnson syndrome"
Show Display Options
Rank Status Study
1 Completed Stevens-Johnson Syndrome Antimicrobial
Condition: Stevens-Johnson Syndrome
2 Completed Phase III Clinical Trial of NPB-01 in Patients With Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis Unresponsive to Corticosteroids.
Conditions: Stevens-Johnson Syndrome;   Toxic Epidermal Necrolysis
Intervention: Drug: Intravenous immunoglobulin
3 Completed Efficacy of 0.05% Cyclosporin Eye Drop in Stevens Johnson Syndrome Patient With Chronic Dry Eye
Condition: Stevens-Johnson Syndrome
Intervention: Drug: 0.05%cyclosporin eye drop
4 Unknown  Corneal Epitheliotropic Factors in Autologous Serum Eye Drops in Nonautoimmune and Stevens-Johnson Syndrome With Dry Eye
Condition: Stevens-Johnson Syndrome
5 Recruiting Infliximab to Improve Retention of the Boston Keratoprosthesis in Patients After Stevens Johnson Syndrome/ Toxic Epidermal Necrolysis (SJS/TENS)
Conditions: Stevens-Johnson Syndrome;   Corneal Blindness
Intervention: Drug: Infliximab
6 Enrolling by invitation Salivary Gland Transplantation in the Treatment of Dry Eye in Patients With Stevens-Johnson Syndrome.
Conditions: Symblepharon;   Dry Eye;   Ocular Surface Disease;   Transplantation
Intervention: Procedure: Salivary Gland and Labial Mucous Membrane Transplantation
7 Not yet recruiting Topical Infliximab in Autoimmune Eyes With Keratoprosthesis
Conditions: Stevens-Johnson Syndrome;   Toxic Epidermal Necrolysis (Lyell) Syndrome;   Mucous Membrane Pemphigoid
Intervention: Drug: topical infliximab
8 Completed Autologous ex Vivo Conjunctival Epithelial Cell Expansion for Ocular Surface Transplantation
Conditions: Pterygium;   Ocular Surface Disease;   Stevens Johnson Syndrome;   Chemical Injury
Intervention: Procedure: Cultivated conjunctival transplantation
9 Recruiting Use of Cross-linked Donor Corneas as Carriers for the Boston Keratoprosthesis
Conditions: Chemical Injuries;   Unspecified Complication of Corneal Transplant;   Autoimmune Diseases;   Ocular Cicatricial Pemphigoid;   Stevens Johnson Syndrome;   Lupus Erythematosus, Systemic;   Rheumatoid Arthritis;   Other Autoimmune Diseases
Intervention: Drug: Riboflavin
10 Recruiting Study to Evaluate the Use of Palifermin to Treat Toxic Epidermal Necrolysis
Conditions: Toxic Epidermal Necrolysis;   Stevens-Johnson Syndrome
Intervention: Drug: Palifermin
11 Withdrawn Study of a Potential New Treatment for Patients With Toxic Epidermal Necrolysis (TEN)
Condition: Toxic Epidermal Necrolysis
Intervention: Drug: Remicaide (infliximab)
12 Active, not recruiting Cultivated Stem Cell Transplantation for the Treatment of Limbal Stem Cell Deficiency
Condition: Limbal Stem Cell Deficiency
Intervention: Procedure: Cultivated limbal stem cell graft transplantation
13 Terminated Lamictal in the Treatment of Post-Herpetic Neuralgia
Condition: Neuralgia, Postherpetic
Intervention: Drug: Lamictal in the treatment of Post-Herpetic Neuralgia

Indicates status has not been verified in more than two years